SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc is seeing intense trading activity driven by a combination of high short interest and anticipation surrounding a potential short squeeze, with the community actively debating whether recent volatility is a setup for a breakout or a temporary pullback. Investors are heavily focused on the stock's growth trajectory and recent business narrative, using technical indicators and social momentum to gauge whether the current price levels offer a strong entry point.

Trump For President

The $TRUMP meme coin is currently experiencing significant volatility following reports of a Mar-a-Lago gala invite for top token holders, sparking intense debate among community members over whether the asset is a legitimate investment or a high-profile pump-and-dump scheme. Critics are actively labeling it a 'grifter coin' and a 'scam,' while vocal supporters continue to rally around the brand amidst broader discussions regarding the political influence of its associated figures.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending amidst intense community debate over the administration's involvement in escalating tensions in the Middle East and its impact on global oil markets. Investors are actively discussing the stock's recent decline, the potential for further volatility due to geopolitical uncertainties, and a wide array of polarized sentiment regarding the company's long-term viability.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power is experiencing significant momentum driven by regulatory approvals in major Western markets and anticipation surrounding its upcoming NASDAQ uplisting. The community remains intensely focused on the company's patented production technology, with active discussions regarding the potential for massive contract scalability and a strategic shift toward defense and industrial supply chains.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is facing downward pressure amid investor concerns over high capital expenditures and a reported delay of its flagship 'Avocado' AI model, leading to significant trading volatility. While the community is debating whether the pullback is a buying opportunity or a signal of deeper structural weakness, traders are closely monitoring key support levels as the company works to scale its internal AI chip infrastructure.

Silvaco Group, Inc. provides technology computer aided design software, electronic data automation software and semiconductor intellectual property. The TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their product's time to market and reduce their development and manufacturing costs. Its services include SPICE Modeling Services, TCAD Modeling Services, Library Design Services and Library Characterization Services. The company was founded on November 18, 2009 and is headquartered in Santa Clara, CA.

Silvaco Group Inc.

Silvaco Group is currently seeing significant momentum and heightened trading volume as market participants closely monitor the stock's ability to hold key support levels. The community is actively discussing the stock's potential for rapid price movement driven by its small-cap nature and institutional interest, while also weighing recent insider purchasing activity against ongoing semiconductor sector volatility.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as investors weigh strong early prescription data for its fibromyalgia drug, Tonmya, against significant concerns over persistent share dilution and the company's financial history. Community discussion is polarized, with bullish investors highlighting recent formulary wins and institutional accumulation as signs of a potential turnaround, while bearish voices continue to emphasize the history of capital raises and downward price pressure.

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Lipocine Inc

Lipocine is currently trending as investors monitor the company's progress toward a year-end NDA submission for its postpartum depression candidate, LPCN 1154. While the community is actively debating the company's cash position and potential for future partnerships, the low float and anticipation surrounding upcoming data catalysts continue to drive significant speculative interest.

PayPay Corp. engages in the development and provision of electronic payment services that include mobile payment. The company was founded on June 15, 2018 and is headquartered in Tokyo, Japan.

PayPay Corp - ADR - Sponsor

PayPay

PayPay is trending due to high volatility and intense retail debate following its recent debut on the Nasdaq as a major fintech IPO. Community discussion is split between those attracted by the company's strong market share and support from institutional investors, and skeptics who are concerned about potential overvaluation and the risks typical of new market entries.

United States Commodity Funds LLC - United States Brent Crude Oil Fund

BNO is trending as investors closely monitor geopolitical escalations and energy supply risks, with community members actively debating whether these tensions will trigger a sustained rally toward higher price levels. Market participants are focusing on the delicate balance between record supply releases and potential global shortages, leading to increased volume as traders rotate into oil for direct exposure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rosalind Advisors Inc. Decreases Stock Position in Ocular Therapeutix, Inc. $OCUL

Rosalind Advisors Inc. decreased its stake in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 67.2% during the 3rd quarter, according to the company in its most recent filing with...

Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?

Relay Therapeutics (RLAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Ocular Therapeutix, Inc. $OCUL Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. raised its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 9.2% during the third quarter, according to the company in its most recent 13F filing with the...

Short Interest in Ocular Therapeutix, Inc. (NASDAQ:OCUL) Grows By 27.8%

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) saw a significant increase in short interest in February. As of February 13th, there was short interest totaling 14,706,215 shares, an...

Ocular Therapeutix Breaks Above 200-Day Moving Average - Bullish for OCUL

In trading on Monday, shares of Ocular Therapeutix Inc (Symbol: OCUL) crossed above their 200 day moving average of $10.98, changing hands as high as $11.00 per share. Ocular Therapeutix Inc shares...

Ocular Therapeutix (NASDAQ:OCUL) Shares Up 17.4% - Should You Buy?

Ocular Therapeutix (NASDAQ:OCUL) Shares Up 17.4% - Should You Buy...

Citigroup Inc. Buys 573,504 Shares of Ocular Therapeutix, Inc. $OCUL

Citigroup Inc. lifted its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 574.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...

Ocular Therapeutix (NASDAQ:OCUL) Cut to Sell at Wall Street Zen

Wall Street Zen lowered Ocular Therapeutix from a "hold" rating to a "sell" rating in a report on Saturday...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fourteen research firms that are covering the company...

Peter Kaiser Sells 2,810 Shares of Ocular Therapeutix (NASDAQ:OCUL) Stock

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) insider Peter Kaiser sold 2,810 shares of Ocular Therapeutix stock in a transaction on Monday, February 23rd. The stock was sold at an average...

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

OCUL
Ocular Therapeutix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest OCUL News

OCULOcular Therapeutix Inc